BIOMAT Database Logo BIOMAT Database Logo

Wnt antagonism inhibits hepatic stellate cell activation and liver fibrosis. 2008

Jason H Cheng, and Hongyun She, and Yuan-Ping Han, and Jiaohong Wang, and Shigang Xiong, and Kinji Asahina, and Hidekazu Tsukamoto
Department of Pathology, Keck School of Medicine of the Univ. of Southern California, Los Angeles, CA 90033-9141, USA.

Activation of hepatic stellate cells (HSC), a key event in liver fibrosis, is caused by diminished adipogenic transcription. This study investigated whether Wnt signaling contributes to "antiadipogenic" activation of HSC and liver fibrogenesis. Culture-activated HSC from normal rats and HSC from cholestatic rat livers were examined for expression of Wnt, Frizzled (Fz) receptors, and coreceptors by quantitative PCR. Wnt signaling was assessed by nuclear beta-catenin and T cell factor (TCF) promoter activity. Dickkopf-1 (Dkk-1), a Wnt coreceptor antagonist, was transduced by an adenoviral vector to assess the effects of Wnt antagonism on culture activation of HSC and cholestatic liver fibrosis in mice. Messenger RNA for canonical (Wnt3a and 10b) and noncanonical (Wnt4 and 5a) Wnt genes, Fz-1 and 2, and coreceptors [low-density lipoprotein-receptor-related protein (LRP)6 and Ryk] are increased approximately 3-12-fold in culture-activated HSC compared with quiescent HSC. The nuclear beta-catenin level and TCF DNA binding are markedly increased in activated HSC. TCF promoter activity is stimulated with Wnt1 but inhibited by Chibby, a protein that blocks beta-catenin interaction with TCF, and by Dkk-1. Dkk-1 enhances peroxisome proliferator-activated receptor-gamma (PPARgamma)-driven PPAR response element (PPRE) promoter activity, a key adipogenic transcriptional parameter, abrogates agonist-stimulated contraction, and restores HSC quiescence in culture. High expression of Dkk-1 increases apoptosis of cultured HSC. Expression of Wnt and Fz genes is also induced in HSC isolated from experimental cholestatic liver fibrosis, and Dkk-1 expression ameliorates this form of liver fibrosis in mice. These results demonstrate antiadipogenic Wnt signaling in HSC activation and therapeutic potential of Wnt antagonism for liver fibrosis.

UI MeSH Term Description Entries
D008026 Ligation Application of a ligature to tie a vessel or strangulate a part. Ligature,Ligations,Ligatures
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008105 Liver Cirrhosis, Biliary FIBROSIS of the hepatic parenchyma due to obstruction of BILE flow (CHOLESTASIS) in the intrahepatic or extrahepatic bile ducts (BILE DUCTS, INTRAHEPATIC; BILE DUCTS, EXTRAHEPATIC). Primary biliary cholangitis involves the destruction of small intra-hepatic bile ducts and decreased bile secretion. Secondary biliary cholangitis is produced by prolonged obstruction of large intrahepatic or extrahepatic bile ducts from a variety of causes. Biliary Cirrhosis,Biliary Cirrhosis, Primary,Biliary Cirrhosis, Secondary,Cholangitis, Chronic Nonsuppurative Destructive,Liver Cirrhosis, Obstructive,Primary Biliary Cholangitis,Biliary Cirrhosis, Primary, 1,Primary Biliary Cirrhosis,Secondary Biliary Cholangitis,Secondary Biliary Cirrhosis,Biliary Cholangitides, Primary,Biliary Cholangitis, Primary,Biliary Cholangitis, Secondary,Cholangitides, Primary Biliary,Cholangitis, Primary Biliary,Cholangitis, Secondary Biliary,Cirrhosis, Biliary,Cirrhosis, Secondary Biliary,Liver Cirrhoses, Biliary,Obstructive Liver Cirrhosis,Primary Biliary Cholangitides,Secondary Biliary Cholangitides
D008297 Male Males
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D011973 Receptors, LDL Receptors on the plasma membrane of nonhepatic cells that specifically bind LDL. The receptors are localized in specialized regions called coated pits. Hypercholesteremia is caused by an allelic genetic defect of three types: 1, receptors do not bind to LDL; 2, there is reduced binding of LDL; and 3, there is normal binding but no internalization of LDL. In consequence, entry of cholesterol esters into the cell is impaired and the intracellular feedback by cholesterol on 3-hydroxy-3-methylglutaryl CoA reductase is lacking. LDL Receptors,Lipoprotein LDL Receptors,Receptors, Low Density Lipoprotein,LDL Receptor,LDL Receptors, Lipoprotein,Low Density Lipoprotein Receptor,Low Density Lipoprotein Receptors,Receptors, Lipoprotein, LDL,Receptor, LDL,Receptors, Lipoprotein LDL
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D002467 Cell Nucleus Within a eukaryotic cell, a membrane-limited body which contains chromosomes and one or more nucleoli (CELL NUCLEOLUS). The nuclear membrane consists of a double unit-type membrane which is perforated by a number of pores; the outermost membrane is continuous with the ENDOPLASMIC RETICULUM. A cell may contain more than one nucleus. (From Singleton & Sainsbury, Dictionary of Microbiology and Molecular Biology, 2d ed) Cell Nuclei,Nuclei, Cell,Nucleus, Cell
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D003135 Common Bile Duct The largest bile duct. It is formed by the junction of the CYSTIC DUCT and the COMMON HEPATIC DUCT. Choledochus,Bile Duct, Common,Common Bile Ducts,Duct, Common Bile

Related Publications

Jason H Cheng, and Hongyun She, and Yuan-Ping Han, and Jiaohong Wang, and Shigang Xiong, and Kinji Asahina, and Hidekazu Tsukamoto
TET1 inhibits liver fibrosis by blocking hepatic stellate cell activation.
February 2024, Journal of gastroenterology and hepatology,
Jason H Cheng, and Hongyun She, and Yuan-Ping Han, and Jiaohong Wang, and Shigang Xiong, and Kinji Asahina, and Hidekazu Tsukamoto
Osthole ameliorates hepatic fibrosis and inhibits hepatic stellate cell activation.
August 2015, Journal of biomedical science,
Jason H Cheng, and Hongyun She, and Yuan-Ping Han, and Jiaohong Wang, and Shigang Xiong, and Kinji Asahina, and Hidekazu Tsukamoto
DCDC2 inhibits hepatic stellate cell activation and ameliorates CCl4-induced liver fibrosis by suppressing Wnt/β-catenin signaling.
April 2024, Scientific reports,
Jason H Cheng, and Hongyun She, and Yuan-Ping Han, and Jiaohong Wang, and Shigang Xiong, and Kinji Asahina, and Hidekazu Tsukamoto
Ginsenoside Rb1 inhibits cell activation and liver fibrosis in rat hepatic stellate cells.
October 2011, Journal of medicinal food,
Jason H Cheng, and Hongyun She, and Yuan-Ping Han, and Jiaohong Wang, and Shigang Xiong, and Kinji Asahina, and Hidekazu Tsukamoto
PLK1 regulates hepatic stellate cell activation and liver fibrosis through Wnt/β-catenin signalling pathway.
July 2020, Journal of cellular and molecular medicine,
Jason H Cheng, and Hongyun She, and Yuan-Ping Han, and Jiaohong Wang, and Shigang Xiong, and Kinji Asahina, and Hidekazu Tsukamoto
ETS1 suppresses hepatic stellate cell activation and liver fibrosis.
December 2025, JCI insight,
Jason H Cheng, and Hongyun She, and Yuan-Ping Han, and Jiaohong Wang, and Shigang Xiong, and Kinji Asahina, and Hidekazu Tsukamoto
Disulfiram inhibits liver fibrosis in rats by suppressing hepatic stellate cell activation and viability.
July 2022, BMC pharmacology & toxicology,
Jason H Cheng, and Hongyun She, and Yuan-Ping Han, and Jiaohong Wang, and Shigang Xiong, and Kinji Asahina, and Hidekazu Tsukamoto
Salvianolic acid B inhibits hepatic stellate cell activation and liver fibrosis by targeting PDGFRβ.
September 2023, International immunopharmacology,
Jason H Cheng, and Hongyun She, and Yuan-Ping Han, and Jiaohong Wang, and Shigang Xiong, and Kinji Asahina, and Hidekazu Tsukamoto
MCPIP1 Inhibits Hepatic Stellate Cell Activation in Autocrine and Paracrine Manners, Preventing Liver Fibrosis.
February 2024, Cellular and molecular gastroenterology and hepatology,
Jason H Cheng, and Hongyun She, and Yuan-Ping Han, and Jiaohong Wang, and Shigang Xiong, and Kinji Asahina, and Hidekazu Tsukamoto
β-catenin is overexpressed in hepatic fibrosis and blockage of Wnt/β-catenin signaling inhibits hepatic stellate cell activation.
June 2014, Molecular medicine reports,
Copied contents to your clipboard!